Work

Time to First and Sustained Improvement in Weekly Migraine Days Among Patients Receiving Preventive Treatment With Rimegepant 75 mg (P9-12.005)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211168

Authors: Stewart Tepper, Lucy Abraham, Andrew Bushmakin, Joseph Cappelleri, Terence Fullerton, Jiyue Yang, Richard Lipton

Institutions: New England Institute for Neurology and Headache, Pfizer (United Kingdom), Pfizer (United States), Albert Einstein College of Medicine

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409237371

FWCI:

Cites:

Cited by:

Related to: 10